Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?

Marc K. Halushka; Perry V. Halushka

doi:10.1161/01.CIR.0000015422.86569.52

Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A₂?

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1620-1622
Number of pages	3
Journal	Circulation
Volume	105
Issue number	14
DOIs	https://doi.org/10.1161/01.CIR.0000015422.86569.52
State	Published - Apr 9 2002
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/01.CIR.0000015422.86569.52

Cite this

@article{4166eedc7fbc4b5ba829d8086634398c,

title = "Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?",

author = "Halushka, {Marc K.} and Halushka, {Perry V.}",

year = "2002",

month = apr,

day = "9",

doi = "10.1161/01.CIR.0000015422.86569.52",

language = "English (US)",

volume = "105",

pages = "1620--1622",

journal = "Circulation",

issn = "0009-7322",